← Back to News

Click Chemistry Phase 2a results of SQ3370 in STS patients

June 1, 2024

Phase 2a results of SQ3370, a doxorubicin-based click chemistry therapeutic in advanced STS patients (planned interim analysis)

View the presented poster here

Want to stay up to date on our news? 
Follow us on LinkedIn